


Searching News Database: TEMSO trial
HSMN NewsFeed - 30 Aug 2010
Teriflunomide Significantly Reduced Annualized Relapse Rate and was Well Tolerated in MS Patients
Teriflunomide Significantly Reduced Annualized Relapse Rate and was Well Tolerated in MS Patients
